CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 115 filers reported holding CHINA BIOLOGIC PRODS INC in Q2 2017. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $31,488,000 | -5.6% | 278,407 | -1.5% | 3.45% | -21.3% |
Q1 2017 | $33,341,000 | +85.6% | 282,550 | +69.1% | 4.39% | +88.3% |
Q4 2016 | $17,967,000 | -41.1% | 167,104 | -31.9% | 2.33% | -19.3% |
Q3 2016 | $30,527,000 | -17.8% | 245,237 | -29.8% | 2.89% | -19.7% |
Q2 2016 | $37,128,000 | -14.3% | 349,210 | -7.7% | 3.60% | -14.9% |
Q1 2016 | $43,333,000 | +50.1% | 378,518 | +86.8% | 4.22% | +4.6% |
Q4 2015 | $28,862,000 | +542.7% | 202,600 | +305.2% | 4.04% | +573.2% |
Q3 2015 | $4,491,000 | – | 50,000 | – | 0.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SPQ Asia Capital Ltd | 228,777 | $24,597,000 | 12.30% |
Ariose Capital Management Ltd | 238,841 | $25,680,000 | 8.36% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 8,400 | $903,000 | 3.21% |
RUDMAN ERROL M | 37,001 | $3,978,000 | 2.76% |
INDUS CAPITAL PARTNERS, LLC | 167,104 | $17,967,000 | 2.33% |
Ativo Capital Management LLC | 90,748 | $9,757,000 | 2.30% |
THOMAS WHITE INTERNATIONAL LTD | 130,130 | $13,991,000 | 2.08% |
OBERWEIS ASSET MANAGEMENT INC/ | 55,855 | $6,006,000 | 1.80% |
Cormorant Asset Management, LP | 112,867 | $12,135,000 | 1.64% |
BARING ASSET MANAGEMENT Ltd | 143,512 | $15,430,000 | 1.06% |